Atypical inflammation in the central nervous system in prion disease.
about
A systems approach to prion diseaseMicroglia and neuroinflammation: a pathological perspectiveInsights into Mechanisms of Chronic NeurodegenerationThe diverse roles of mononuclear phagocytes in prion disease pathogenesisCalcineurin inhibition at the clinical phase of prion disease reduces neurodegeneration, improves behavioral alterations and increases animal survivalEarly-life programming of later-life brain and behavior: a critical role for the immune system.Subcellular localization of disease-associated prion protein in the human brain.Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genesA common carcinogen benzo[a]pyrene causes neuronal death in mouse via microglial activation.The intricate mechanisms of neurodegeneration in prion diseases.WNT signaling in activated microglia is proinflammatory.Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.Phosphorylation of mitogen- and stress-activated protein kinase-1 in astrocytic inflammation: a possible role in inhibiting production of inflammatory cytokines.Microglial Cx3cr1 knockout reduces prion disease incubation time in miceRole of cyclophilin A from brains of prion-infected mice in stimulation of cytokine release by microglia and astroglia in vitroIdentification of Major Signaling Pathways in Prion Disease Progression Using Network Analysis.Antiprion immunotherapy: to suppress or to stimulate?Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures.Storage solutions: treating lysosomal disorders of the brain.Neuroinflammation: a potential therapeutic target.An In Vivo (11)C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease.Prior exposure to repeated morphine potentiates mechanical allodynia induced by peripheral inflammation and neuropathy.Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation.Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease.Investigation of mcp1 as a quantitative trait gene for prion disease incubation time in mouse.Microglia play a major role in direct viral-induced demyelinationThe brain as a target for inflammatory processes and neuroprotective strategies.Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration.Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions.Heterogeneity of microglial activation in the innate immune response in the brain.Accelerated prion disease in the absence of interleukin-10.The role of microglia in synaptic stripping and synaptic degeneration: a revised perspective.Review: activation patterns of microglia and their identification in the human brain.Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology.Multitarget ligands and theranostics: sharpening the medicinal chemistry sword against prion diseases.Protective role of cellular prion protein against TNFα-mediated inflammation through TACE α-secretase.Age-Dependent Changes in the Activation and Regulation of Microglia.Peripheral Inflammation and Demyelinating Diseases.The Role of Microglia in Prion Diseases: A Paradigm of Functional Diversity.
P2860
Q24656032-86292EB2-0F6B-472D-B122-E1AD5A439D16Q24799838-F821F772-8911-4905-8FCA-6A47896CE2C5Q26771732-F061252E-E964-4645-ABF7-DC401179E99DQ26823101-2310CEE9-5338-44E9-975A-ADD993104435Q27313215-106D0152-CB9A-4BAF-AF31-85C7AF2BB259Q30487006-2BE3411B-9FF2-41B6-8391-07655E5EE90BQ33210582-ACEA2108-1BDE-4CF4-AF80-343DCF329932Q33322227-E4FDD83C-B77E-49C0-94CE-A5EF90A2AA5BQ33550764-AD2C89AE-2D9D-45F3-A5D2-DED61C12EE3DQ34664576-DEB1DB88-7C3E-47CB-BF17-E4A89306247EQ34722036-E205D16A-F88F-43F2-8396-D57755E632B6Q35059951-087821E2-36B8-437F-9120-CEA08AACF274Q35069769-D19C68E1-904A-435E-8E52-5FB8EC19DF80Q35127326-91898F2C-CCC8-4971-91CD-1C8125E80042Q35763031-3FBBC899-CE7B-47FB-9F92-E5ACDF2EAD6CQ35863572-32EB403E-CBB0-4D2C-9D64-3EE99A457841Q35877214-661CBF6B-D34F-4A02-9297-782AE3E81EBEQ35881742-86FE17FB-5995-4557-880E-340B463B03F4Q36210235-37DBB8CE-36FF-4149-B0CC-07C621C43C92Q36268282-D8DAA405-774F-44E8-B201-091995C8785CQ36358771-76FF3F13-46F7-44E3-A3D3-D3C1D1030DCAQ36377051-F793A8FE-0CCA-4A6C-87B5-2B558D2E73B5Q36400800-4690AC4D-5D83-41D6-A9CB-CC43831324CEQ36741828-180C7371-2978-4104-9EDC-5F7E494517C4Q36873781-D48EF094-9E5A-416A-81F2-4784728F74E7Q36995320-7A7217B7-2C2E-4A34-99D1-82B33B4D77B2Q37031200-CC162962-BDB1-4EAF-AB02-F47403058726Q37093985-C6393C27-22B5-4433-82DE-BE8E5E0AD874Q37448617-706FF340-4C24-4670-BF51-445BCFEB4C27Q37572598-5B4025A4-79C9-420B-840C-37AAE3FE9EACQ37683272-D335BA39-E6ED-4AD4-9D6E-4A8A23DCEE27Q37802202-87412C20-BE2A-474B-9A8E-2DA0E9EFD2F2Q38068503-CD4C6E43-0082-4FB6-9051-E33569369738Q38103856-CC4B4571-5B47-4F46-BF4C-1CCFF74926AAQ38131730-F51ACB6F-3EE3-442D-9E87-1804060D4310Q38234645-11B58A61-18A7-4EBC-B673-3F0A100D05BDQ38631578-F8416F16-AF9A-401F-A478-C2B34EA6431FQ38974741-542104C6-AF4B-4A1C-9381-AF35B0175111Q38974745-06143FC9-3BC0-4927-A9B7-79C577ABDC03Q39424451-4CB01D18-D3A7-44EA-A12F-B245069F80D8
P2860
Atypical inflammation in the central nervous system in prion disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Atypical inflammation in the central nervous system in prion disease.
@ast
Atypical inflammation in the central nervous system in prion disease.
@en
Atypical inflammation in the central nervous system in prion disease.
@nl
type
label
Atypical inflammation in the central nervous system in prion disease.
@ast
Atypical inflammation in the central nervous system in prion disease.
@en
Atypical inflammation in the central nervous system in prion disease.
@nl
prefLabel
Atypical inflammation in the central nervous system in prion disease.
@ast
Atypical inflammation in the central nervous system in prion disease.
@en
Atypical inflammation in the central nervous system in prion disease.
@nl
P1476
Atypical inflammation in the central nervous system in prion disease.
@en
P2093
V Hugh Perry
P304
P356
10.1097/00019052-200206000-00020
P577
2002-06-01T00:00:00Z